Article
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.
International journal of molecular medicine - 1 Dec 2011
Provenzani Alessio, Notarbartolo Monica, Labbozzetta Manuela, Poma Paola, Vizzini Giovanni, Salis Paola, Caccamo Chiara, Bertani Tullio, Palazzo Ugo, Polidori Piera, Gridelli Bruno, D'Alessandro Natale
Abstract excerpt
Tacrolimus is a substrate of cytochrome P4503A (CYP3A) enzymes as well as of the drug transporter ABCB1. We have investigated the possible influence of CYP3A5 and ABCB1 single nucleotide polymorphisms (SNPs) and other factors (e.g. albumin, hematocrit and steroids) on tacrolimus blood levels achieved in a population of Caucasian liver (n=51) and kidney (n=50) transplant recipients. At 1, 3 and 6 months after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
